U.S. markets close in 20 minutes

Rubius Therapeutics, Inc. (RUBY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
25.42+1.87 (+7.94%)
As of 3:39PM EDT. Market open.

Rubius Therapeutics, Inc.

399 Binney Street
Suite 300
Cambridge, MA 02139
United States
617 679 9600

Full Time Employees231

Key Executives

NameTitlePayExercisedYear Born
Mr. David R. EpsteinExec. Chairman495kN/A1962
Dr. Pablo J. Cagnoni Ph.D., M.D.CEO, Pres & Director1.01MN/A1963
Mr. Laurence A. Turka M.D.Chief Scientific Officer704.94kN/A1958
Dr. Christina M. Coughlin B.S., M.D., Ph.D.Chief Medical Officer700.97kN/A1970
Mr. Jose I. CarmonaCFO, Principal Accounting Officer & TreasurerN/AN/A1972
Ms. Joanne M. ProtanoSr. VP of Fin. & OperationsN/AN/A1969
Mr. Spencer FiskSr. VP of Manufacturing & CTON/AN/AN/A
Ms. Lori MelanconChief Corp. Affairs OfficerN/AN/AN/A
Ms. Elhan Webb C.F.A.VP of Investor RelationsN/AN/AN/A
Ms. Maiken Keson-BrookesChief Legal Officer & Corp. Sec.N/AN/A1973
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of cancer; and RTX-aAPC to treat solid and hematological cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Corporate Governance

Rubius Therapeutics, Inc.’s ISS Governance QualityScore as of April 30, 2021 is 8. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.